|
Response to Industry Claims on Price Differences |
 |
 |
|
Congressional reports have shown that seniors without prescription drug coverage must pay
substantially more for popular brand-name drugs in the United States than in other countries.
The reports find, for example, that the ulcer medication Prilosec, the top-selling prescription drug
in United States in 2000, costs twice as much in the United States as in Canada. Celebrex, the
popular arthritis drug, sells for over two and a half times as much in the United States as it does
in France. The drug industry has attempted to discredit these findings. This fact sheet analyzes
the industry’s claims. |
